DOCSLIB.ORG

Bacterial Toxigenesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bacterial Toxigenesis Bacterial Toxigenesis Food Toxicology Instructor: Gregory Möller, Ph.D. University of Idaho Learning Objectives • Define bacterial toxigenesis. • Explore bacterial toxins, their background and nomenclature. • Differentiate exotoxins and endotoxins. • Explore the toxicity, properties, and mode of action of exotoxins. • Understand the toxicity, properties, and mode of action of endotoxins (pyrogens). • Understand the origins of sepsis. • Review the detection of endotoxins. Bacterial Toxigenesis • The ability to produce toxins: a mechanism of bacterial disease. • Cell-associated lipopolysaccharide (LPS) toxins are referred to as endotoxins. • Extracellular diffusible toxins are referred to as exotoxins. Bacterial Toxins • ‘[Substances] that are toxic to eukaryotic cells as measured in a variety of ways’, Orndorff 1992 • ‘A microbial substance able to induce host damage’, Madigan et al. 1997 • ‘Any organic microbial product or substance that is harmful or lethal to cells, tissue cultures, or organisms’, Atlas 1995 Bacterial Toxins • ‘[Toxins are] a common and series cause of tissue damage, especially in bacterial infection’, Mims et al. 1993; • ‘Disease is frequently determined by production of microbial toxins’, Murray et al. 1994 • ‘Bacterial [toxins] are thus important determinants of bacterial virulence’ Poxton and Arbuthnott 1990 Bacterial Toxins • ‘Microbial toxins are components or products of microorganisms which, when extracted and introduced into host animals, can reproduce disease symptoms normally associated with infection without infestation by those microorganisms’, Williams and Clarke, 1998 Bacterial Toxins • Terms – Exotoxin = extracellular protein toxin – Endotoxin = lipid A portion of Gram-neg outer membrane – Enterotoxin = toxin that acts on gastrointestinal tract, producing typical food poisoning symptoms • Nomenclature – Named for host cell attacked: cytotoxin, neurotoxin – Named for producer or disease: cholera, Shiga – Named for activity: lecithinase, adenylate cyclase – Letter designation: exotoxin A Endotoxins and Exotoxins • Endotoxins are cell-associated substances that are structural components of the outer membrane of Gram-negative bacteria. – Released from growing bacterial cells – Released from cells which are lysed from effective host defense (e.g. lysozyme) – Released from activities of certain antibiotics (e.g. penicillins) • Exotoxins usually secreted by bacteria but in some cases they are released by lysis of the bacterial cell. Exotoxins • Most well-characterized family of toxins. • Secreted by bacterium as soluble proteins. • Enter eukaryotic cells primarily through receptor-mediated endocytosis. • Exotoxin-mediated infections: – Involve local colonization of host – Exotoxin-mediated systemic disease, which often occurs distal to the site of infection. Types of Exotoxins • Membrane-acting toxins • Toxins with cytosolic targets Mode of Action • Damage membranes – Forms pores • Inhibit protein synthesis – N-glycosidase • Activate 2nd messenger pathways – ADP-ribosyltransferase • Activate immune response – Superantigen • Protease – Zinc-metalloprotease Exotoxins: Bacterial Protein Toxins • Exotoxins are typically soluble proteins secreted by living bacteria. – Both Gram-positive and Gram-negative bacteria produce soluble protein toxins. • A specific toxin is generally specific to a particular bacterial species – e.g. only Clostridium tetani produces tetanus toxin; – Only Corynebacterium diphtheriae produces the diphtheria toxin. Exotoxins: Virulence • Usually, virulent strains of the bacterium produce the toxin while non-virulent strains do not – The toxin is the major determinant of virulence. Exotoxin Lethal Toxicity Comparison Protein Toxins: Resemble Enzymes • Denatured by heat, acid, and proteolytic enzymes • High biological activity • Most act catalytically • Highly specific in the substrate utilized – Tissue cells, organs, or body fluid • Highly specific mode of action. • Site of damage caused by the toxin indicates the location of the substrate. – Enterotoxin, neurotoxin, leukocidin, or hemolysin. Protein Toxins: Cytotoxic Activity • Certain protein toxins have very specific cytotoxic activity – Attack specific types of cells. – e.g. tetanus or botulinum toxins attack only neurons. • Some toxins have fairly broad cytotoxic activity and cause nonspecific death of all sorts of cells and tissues, eventually resulting in necrosis. – Staphylococci, streptococci, clostridia, etc. • Some broadly lethal but with unknown specifics – e.g. anthrax toxin LF. Protein Toxins: Strongly Antigenic • In vivo antibody (antitoxin) neutralizes the toxicity of bacterial proteins. • Protein toxins are inherently unstable – In time they lose their toxic properties but retain their antigenic properties. • Toxoids are detoxified toxins which retain their antigenicity and their immunizing capacity. Protein Toxins: Toxoids • The formation of toxoids can be accelerated by treating toxins with a variety of reagents – Formalin, iodine, pepsin, ascorbic acid, ketones, etc. – 37ºC, pH 6-9 for several weeks. • Resulting toxoids can be use for artificial immunization where the primary determinant of bacterial virulence is toxin production. – e.g. diphtheria and tetanus. • Toxoids can be genetically engineered. Gram-Negative Bacteria: Endotoxins • An important part of the toxicity of these organisms is conferred through the release of endotoxins, as occurs in septicemia, toxic shock syndrome, and sometimes in food poisoning. • Endotoxins = lipopolysaccharides. – A part of cell membrane envelopes. • Killed bacteria can release endotoxins as they decay. – E. coli, Salmonella, Shigella, Pseudomonas, Neisseria, Haemophilus, and other pathogens. Endotoxins (Pyrogens) • Cause a wide variety of serious reactions such as fever, shock, changes in blood pressure, and in other circulatory functions. Endotoxins • Endotoxins are toxic to most mammals • Regardless of the bacterial source, all endotoxins produce the same range of biological effects in the animal host. • Most of our knowledge of the biological activities of endotoxins derives not from the study of natural disease but by challenge of experimental animals. Endotoxins • The injection of living or killed Gram-negative cells, or purified LPS, into experimental animals causes a wide spectrum of nonspecific pathophysiological reactions. • Includes: fever, changes in white blood cell counts, disseminated intravascular coagulation, hypotension, shock and death. Endotoxins • Injection of fairly small doses of endotoxin results in death in most mammals. • The sequence of events follows a regular pattern: (1) latent period; (2) physiological distress - Diarrhea, prostration, shock (3) death. • How soon death occurs varies on the dose of the endotoxin, route of administration, and species of animal. – Animals vary in their susceptibility to endotoxin. Exotoxins and Endotoxins • Compared to the classic exotoxins of bacteria, endotoxins are less potent and less specific in their action, since they do not act enzymatically. • Endotoxins are heat stable (boiling for 30 min does not destabilize endotoxin) – Certain powerful oxidizing agents such as superoxide, peroxide and hypochlorite, have been reported to neutralize them. • Endotoxins, although antigenic, cannot be converted to toxoids. Characteristics of Endotoxins/Exotoxins Role of Toxins in Foodborne Disease • Consumed as pre-formed → self-limiting • Produced by colonized bacteria → local or distal effect • Produced by infecting bacteria to aid invasion • Autoimmune response to superantigens • Endotoxin elicits immune response → shock Organisms Recognized for Foodborne Intoxications • Staphylococcus aureus – Enterotoxins • Clostridium botulinum – Neurotoxin • Clostridium perfringens – Enterotoxin, other toxins • Bacillus cereus – Diarrheagenic and emetic toxins • Vibrio cholerae – Cholera toxin • enterotoxigenic E. coli – Heat-stable & heat-labile toxins Agents of Foodborne Infections That Also Produce Toxins • Shigella sp. – Shiga toxin • Listeria monocytogenes – Listeriolysin • Salmonella sp. – Enterotoxin, cytotoxin • enterohemorrhagic E. coli – Shiga-like toxin • Vibrio parahaemolyticus – Hemolysin • Yersinia enterocolitica – Enterotoxin Bacterial Cell Structures Bacterial Cell Wall Bacterial Cell Wall Gram-Positive Cell Wall Gram-Negative Cell Wall Lipoplysaccharide (LPS) GNB • Major constituent of outer surface of the outer membrane • Covers ~75% of the OM • Gives colonies a smooth appearance • ~3-10% of the total dry cell weight • 3-4 million LPS molecules per cell Lipopolysaccharide Structure LPS Lipid A • Lipid A is a powerful biological response modifier that can stimulate the mammalian immune system. – During infectious disease caused by Gram - bacteria, endotoxins released from, or part of, multiplying cells have similar effects on animals and significantly contribute to the symptoms and pathology of the disease encountered. Lipopolysaccharide Lipid A LPS Mode of Action • Bound by plasma proteins LPS-binding proteins (LBP). • LBP interacts with receptors on monocytes and macrophages and other types of receptors on endothelial cells. • In monocytes and macrophages three types of events are triggered during their interaction with LPS: 1) Production of cytokines, (IL, TNF, etc.) which stimulate production of prostaglandins and leukotrienes (powerful mediators of inflammation and septic shock). 2) Activation of the complement cascade. (cause histamine release leading to vasodilation) and effect neutrophil chemotaxis
Load more

Recommended publications
  • The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections
    toxins Review The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections Patience Shumba 1, Srikanth Mairpady Shambat 2 and Nikolai Siemens 1,* 1 Center for Functional Genomics of Microbes, Department of Molecular Genetics and Infection Biology, University of Greifswald, D-17489 Greifswald, Germany; [email protected] 2 Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, CH-8091 Zurich, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +49-3834-420-5711 Received: 20 May 2019; Accepted: 10 June 2019; Published: 11 June 2019 Abstract: Necrotizing soft tissue infections (NSTIs) are critical clinical conditions characterized by extensive necrosis of any layer of the soft tissue and systemic toxicity. Group A streptococci (GAS) and Staphylococcus aureus are two major pathogens associated with monomicrobial NSTIs. In the tissue environment, both Gram-positive bacteria secrete a variety of molecules, including pore-forming exotoxins, superantigens, and proteases with cytolytic and immunomodulatory functions. The present review summarizes the current knowledge about streptococcal and staphylococcal toxins in NSTIs with a special focus on their contribution to disease progression, tissue pathology, and immune evasion strategies. Keywords: Streptococcus pyogenes; group A streptococcus; Staphylococcus aureus; skin infections; necrotizing soft tissue infections; pore-forming toxins; superantigens; immunomodulatory proteases; immune responses Key Contribution: Group A streptococcal and Staphylococcus aureus toxins manipulate host physiological and immunological responses to promote disease severity and progression. 1. Introduction Necrotizing soft tissue infections (NSTIs) are rare and represent a more severe rapidly progressing form of soft tissue infections that account for significant morbidity and mortality [1].
    [Show full text]
  • How Do Pathogenic Microorganisms Develop Cross-Kingdom Host Jumps? Peter Van Baarlen1, Alex Van Belkum2, Richard C
    Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps? Peter van Baarlen1, Alex van Belkum2, Richard C. Summerbell3, Pedro W. Crous3 & Bart P.H.J. Thomma1 1Laboratory of Phytopathology, Wageningen University, Wageningen, The Netherlands; 2Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands; and 3CBS Fungal Biodiversity Centre, Utrecht, The Netherlands Correspondence: Bart P.H.J. Thomma, Abstract Downloaded from https://academic.oup.com/femsre/article/31/3/239/2367343 by guest on 27 September 2021 Laboratory of Phytopathology, Wageningen University, Binnenhaven 5, 6709 PD It is common knowledge that pathogenic viruses can change hosts, with avian Wageningen, The Netherlands. Tel.: 10031 influenza, the HIV, and the causal agent of variant Creutzfeldt–Jacob encephalitis 317 484536; fax: 10031 317 483412; as well-known examples. Less well known, however, is that host jumps also occur e-mail: [email protected] with more complex pathogenic microorganisms such as bacteria and fungi. In extreme cases, these host jumps even cross kingdom of life barriers. A number of Received 3 July 2006; revised 22 December requirements need to be met to enable a microorganism to cross such kingdom 2006; accepted 23 December 2006. barriers. Potential cross-kingdom pathogenic microorganisms must be able to First published online 26 February 2007. come into close and frequent contact with potential hosts, and must be able to overcome or evade host defences. Reproduction on, in, or near the new host will DOI:10.1111/j.1574-6976.2007.00065.x ensure the transmission or release of successful genotypes.
    [Show full text]
  • Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
    toxins Review Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease Rosalia Marcano 1, M. Ángeles Rojo 2 , Damián Cordoba-Diaz 3 and Manuel Garrosa 1,* 1 Department of Cell Biology, Histology and Pharmacology, Faculty of Medicine and INCYL, University of Valladolid, 47005 Valladolid, Spain; [email protected] 2 Area of Experimental Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain; [email protected] 3 Area of Pharmaceutics and Food Technology, Faculty of Pharmacy, and IUFI, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Abstract: It is widely recognized that periodontal disease is an inflammatory entity of infectious origin, in which the immune activation of the host leads to the destruction of the supporting tissues of the tooth. Periodontal pathogenic bacteria like Porphyromonas gingivalis, that belongs to the complex net of oral microflora, exhibits a toxicogenic potential by releasing endotoxins, which are the lipopolysaccharide component (LPS) available in the outer cell wall of Gram-negative bacteria. Endotoxins are released into the tissues causing damage after the cell is lysed. There are three well-defined regions in the LPS: one of them, the lipid A, has a lipidic nature, and the other two, the Core and the O-antigen, have a glycosidic nature, all of them with independent and synergistic functions. Lipid A is the “bioactive center” of LPS, responsible for its toxicity, and shows great variability along bacteria. In general, endotoxins have specific receptors at the cells, causing a wide immunoinflammatory response by inducing the release of pro-inflammatory cytokines and the production of matrix metalloproteinases.
    [Show full text]
  • Nasopharyngeal Infection by Streptococcus Pyogenes Requires Superantigen-Responsive Vβ-Specific T Cells
    Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells Joseph J. Zeppaa, Katherine J. Kaspera, Ivor Mohorovica, Delfina M. Mazzucaa, S. M. Mansour Haeryfara,b,c,d, and John K. McCormicka,c,d,1 aDepartment of Microbiology and Immunology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada; bDepartment of Medicine, Division of Clinical Immunology & Allergy, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5A5, Canada; cCentre for Human Immunology, Western University, London, ON N6A 5C1, Canada; and dLawson Health Research Institute, London, ON N6C 2R5, Canada Edited by Philippa Marrack, Howard Hughes Medical Institute, National Jewish Health, Denver, CO, and approved July 14, 2017 (received for review January 18, 2017) The globally prominent pathogen Streptococcus pyogenes secretes context of invasive streptococcal disease is extremely dangerous, potent immunomodulatory proteins known as superantigens with a mortality rate of over 30% (10). (SAgs), which engage lateral surfaces of major histocompatibility The role of SAgs in severe human infections has been well class II molecules and T-cell receptor (TCR) β-chain variable domains established (5, 11, 12), and specific MHC-II haplotypes are known (Vβs). These interactions result in the activation of numerous Vβ- risk factors for the development of invasive streptococcal disease specific T cells, which is the defining activity of a SAg. Although (13), an outcome that has been directly linked to SAgs (14, 15). streptococcal SAgs are known virulence factors in scarlet fever However, how these exotoxins contribute to superficial disease and and toxic shock syndrome, mechanisms by how SAgs contribute colonization is less clear.
    [Show full text]
  • Instability of Toxin a Subunit of AB5 Toxins in the Bacterial Periplasm Caused by Deficiency of Their Cognate B Subunits
    Biochimica et Biophysica Acta 1808 (2011) 2359–2365 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamem Instability of toxin A subunit of AB5 toxins in the bacterial periplasm caused by deficiency of their cognate B subunits Sang-Hyun Kim a, Su Hyang Ryu a, Sang-Ho Lee a, Yong-Hoon Lee a, Sang-Rae Lee a, Jae-Won Huh a, Sun-Uk Kim a, Ekyune Kim d, Sunghyun Kim b, Sangyong Jon b, Russell E. Bishop c,⁎, Kyu-Tae Chang a,⁎⁎ a The National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Chungbuk 363–883, Republic of Korea b School of Life Science, Gwangju Institute of Science and Technology (GIST), 1 Oryong-dong, Gwangju 500–712, Republic of Korea c Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5 d College of Pharmacy, Catholic University of Daegu, Hayang-eup, Gyeongsan, Gyeongbuk 712-702, Republic of Korea article info abstract Article history: Shiga toxin (STx) belongs to the AB5 toxin family and is transiently localized in the periplasm before secretion Received 26 April 2011 into the extracellular milieu. While producing outer membrane vesicles (OMVs) containing only A subunit of Received in revised form 3 June 2011 the toxin (STxA), we created specific STx1B- and STx2B-deficient mutants of E. coli O157:H7. Surprisingly, Accepted 23 June 2011 STxA subunit was absent in the OMVs and periplasm of the STxB-deficient mutants. In parallel, the A subunit Available online 5 July 2011 of heat-labile toxin (LT) of enterotoxigenic E.
    [Show full text]
  • Mycotoxin Analysis in Infant Formula Using Captiva EMR-Lipid
    Application Note Food Testing & Agriculture Mycotoxin Analysis in Infant Formula Using Captiva EMR—Lipid Cleanup and LC/MS/MS Author Abstract Derick Lucas Agilent Technologies, Inc. Several countries regulate the levels of mycotoxins in foods. However, the complexity of certain foodstuffs in terms of protein and lipid content can prove challenging in the accurate quantitation of low-level mycotoxins in these matrices. This Application Note describes the determination of 13 multiclass mycotoxins in solid and liquid infant formulations using a Quick Easy Cheap Effective Rugged Safe (QuEChERS) workflow followed by Agilent Captiva EMR—Lipid cartridge cleanup. Due to the high selectivity of the Captiva EMR—Lipid sorbent, excellent recoveries (70.4 to 106.8 %) and precision (<18 %) were achieved for all mycotoxins. This simple and robust methodology requires minimal equipment and expertise, which promotes easy implementation in food laboratories. Introduction Experimental Mycotoxins are produced as secondary metabolites by fungal Sample preparation species that grow on various crops such as grain, corn, and • Captiva EMR—Lipid 3-mL tubes (p/n 5190-1003) nuts. When cows ingest contaminated feed, mycotoxins and their metabolites can be excreted into the animal’s milk1. • Captiva EMR—Lipid 6-mL tubes (p/n 5190-1004) Aflatoxin M1 is the most commonly found mycotoxin in milk, • QuEChERS original extraction salts (p/n 5982-5550) and is monitored and regulated in many countries, including • VacElut SPS 24 vacuum manifold (p/n 12234022) the United States and European countries2,3. Despite a lack of regulations for other mycotoxins in milk, there is a growing LC configuration and parameters interest to monitor additional mycotoxins such as fumonisins and ochratoxins.
    [Show full text]
  • Impact of Bacterial Toxins in the Lungs
    toxins Review Impact of Bacterial Toxins in the Lungs 1,2,3, , 4,5, 3 2 Rudolf Lucas * y, Yalda Hadizamani y, Joyce Gonzales , Boris Gorshkov , Thomas Bodmer 6, Yves Berthiaume 7, Ueli Moehrlen 8, Hartmut Lode 9, Hanno Huwer 10, Martina Hudel 11, Mobarak Abu Mraheil 11, Haroldo Alfredo Flores Toque 1,2, 11 4,5,12,13, , Trinad Chakraborty and Jürg Hamacher * y 1 Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; hfl[email protected] 2 Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 3 Department of Medicine and Division of Pulmonary Critical Care Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 4 Lungen-und Atmungsstiftung, Bern, 3012 Bern, Switzerland; [email protected] 5 Pneumology, Clinic for General Internal Medicine, Lindenhofspital Bern, 3012 Bern, Switzerland 6 Labormedizinisches Zentrum Dr. Risch, Waldeggstr. 37 CH-3097 Liebefeld, Switzerland; [email protected] 7 Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada; [email protected] 8 Pediatric Surgery, University Children’s Hospital, Zürich, Steinwiesstrasse 75, CH-8032 Zürch, Switzerland; [email protected] 9 Insitut für klinische Pharmakologie, Charité, Universitätsklinikum Berlin, Reichsstrasse 2, D-14052 Berlin, Germany; [email protected] 10 Department of Cardiothoracic Surgery, Voelklingen Heart Center, 66333
    [Show full text]
  • Chemical Strategies to Target Bacterial Virulence
    Review pubs.acs.org/CR Chemical Strategies To Target Bacterial Virulence † ‡ ‡ † ‡ § ∥ Megan Garland, , Sebastian Loscher, and Matthew Bogyo*, , , , † ‡ § ∥ Cancer Biology Program, Department of Pathology, Department of Microbiology and Immunology, and Department of Chemical and Systems Biology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305, United States ABSTRACT: Antibiotic resistance is a significant emerging health threat. Exacerbating this problem is the overprescription of antibiotics as well as a lack of development of new antibacterial agents. A paradigm shift toward the development of nonantibiotic agents that target the virulence factors of bacterial pathogens is one way to begin to address the issue of resistance. Of particular interest are compounds targeting bacterial AB toxins that have the potential to protect against toxin-induced pathology without harming healthy commensal microbial flora. Development of successful antitoxin agents would likely decrease the use of antibiotics, thereby reducing selective pressure that leads to antibiotic resistance mutations. In addition, antitoxin agents are not only promising for therapeutic applications, but also can be used as tools for the continued study of bacterial pathogenesis. In this review, we discuss the growing number of examples of chemical entities designed to target exotoxin virulence factors from important human bacterial pathogens. CONTENTS 3.5.1. C. diphtheriae: General Antitoxin Strat- egies 4435 1. Introduction 4423 3.6. Pseudomonas aeruginosa 4435 2. How Do Bacterial AB Toxins Work? 4424 3.6.1. P. aeruginosa: Inhibitors of ADP Ribosyl- 3. Small-Molecule Antivirulence Agents 4426 transferase Activity 4435 3.1. Clostridium difficile 4426 3.7. Bordetella pertussis 4436 3.1.1. C.
    [Show full text]
  • Staphylococcal Enterotoxins
    Toxins 2010, 2, 2177-2197; doi:10.3390/toxins2082177 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Review Staphylococcal Enterotoxins Irina V. Pinchuk 1, Ellen J. Beswick 2 and Victor E. Reyes 3,* 1 Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555-0655, USA; E-Mail: [email protected] 2 Department of Molecular Genetics & Microbiology, University of New Mexico, Albuquerque, NM 87131, USA; E-Mail: [email protected] 3 Departments of Pediatrics and Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555-0366, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-409-772-3824; Fax: +1-409-772-1761. Received: 29 June 2010; in revised form: 9 August 2010 / Accepted: 12 August 2010 / Published: 18 August 2010 Abstract: Staphylococcus aureus (S. aureus) is a Gram positive bacterium that is carried by about one third of the general population and is responsible for common and serious diseases. These diseases include food poisoning and toxic shock syndrome, which are caused by exotoxins produced by S. aureus. Of the more than 20 Staphylococcal enterotoxins, SEA and SEB are the best characterized and are also regarded as superantigens because of their ability to bind to class II MHC molecules on antigen presenting cells and stimulate large populations of T cells that share variable regions on the chain of the T cell receptor. The result of this massive T cell activation is a cytokine bolus leading to an acute toxic shock. These proteins are highly resistant to denaturation, which allows them to remain intact in contaminated food and trigger disease outbreaks.
    [Show full text]
  • Host-Based Lipid Inflammation Drives Pathogenesis in Francisella Infection
    Host-based lipid inflammation drives pathogenesis in Francisella infection Alison J. Scotta, Julia Maria Postb, Raissa Lernerb, Shane R. Ellisc, Joshua Liebermand, Kari Ann Shireye, Ron M. A. Heerenc, Laura Bindilab, and Robert K. Ernsta,1 aDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD 21201; bLaboratory for Eicosanoids and Endocannabinoids, Johannes Gutenberg University Mainz, 55099 Mainz, Germany; cMaastricht MultiModal Molecular Imaging Institute, Maastricht University, 6229 ER Maastricht, The Netherlands; dDepartment of Pathology, University of Washington Medical Center, Seattle, WA 98118; and eDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD 21201 Edited by Roy Curtiss III, University of Florida, Gainesville, FL, and approved October 16, 2017 (received for review July 19, 2017) Mass spectrometry imaging (MSI) was used to elucidate host lipids MSI (18), although other ionization methods [such as desorption involved in the inflammatory signaling pathway generated at the electrospray ionization (DESI) and liquid extraction surface host–pathogen interface during a septic bacterial infection. Using analysis (LESA), and others] are also employed. MSI has been Francisella novicida as a model organism, a bacterial lipid virulence used in a wide array of applications ranging from fingerprint factor (endotoxin) was imaged and identified along with host phos- analysis to mapping drug distribution in tissue. MSI studies of pholipids involved in the splenic response in murine tissues. Here, cancer biology for biomarker discovery, therapeutic target iden- we demonstrate detection and distribution of endotoxin in a lethal tification, and fundamental pathology hold particular promise. In murine F. novicida infection model, in addition to determining the contrast, comparatively few systematic studies have leveraged MSI – temporally and spatially resolved innate lipid inflammatory response to describe the host microbe relationship (19, 20).
    [Show full text]
  • The Evolving Field of Biodefence: Therapeutic Developments and Diagnostics
    REVIEWS THE EVOLVING FIELD OF BIODEFENCE: THERAPEUTIC DEVELOPMENTS AND DIAGNOSTICS James C. Burnett*, Erik A. Henchal‡,Alan L. Schmaljohn‡ and Sina Bavari‡ Abstract | The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents. BACILLUS ANTHRACIS Microorganisms and toxins with the greatest potential small-molecule inhibitors, and a brief review of anti- The causative agent of anthrax for use as biological weapons have been categorized body development and design against biotoxins is and a Gram-positive, spore- using the scale A–C by the Centers for Disease Control mentioned in TABLE 1. forming bacillus. This aerobic and Prevention (CDC). This review covers the discovery organism is non-motile, catalase and challenges in the development of therapeutic coun- Anthrax toxin. The toxin secreted by BACILLUS ANTHRACIS, positive and forms large, grey–white to white, non- termeasures against select microorganisms and toxins ANTHRAX TOXIN (ATX), possesses the ability to impair haemolytic colonies on sheep from these categories. We also cover existing antibiotic innate and adaptive immune responses1–3,which in blood agar plates. treatments, and early detection and diagnostic strategies turn potentiates the bacterial infection.
    [Show full text]
  • Determination of Lipid a and Endotoxin in Serum by Mass Spectroscopy (Ft-Hydroxymyristic Acid/Gas Chromatography-Mass Spectrometry/Gram-Negative Sepsis) SHYAMAL K
    Proc. Nati. Acad. Sci. USA Vol. 75, No. 8, pp. 3993-3997, August 1978 Medical Sciences Determination of lipid A and endotoxin in serum by mass spectroscopy (ft-hydroxymyristic acid/gas chromatography-mass spectrometry/Gram-negative sepsis) SHYAMAL K. MAITRA*t, MICHAEL C. SCHOTZtf, THOMAS T. YOSHIKAWA*t, AND LUCIEN B. GUZE*tl * Research Service, Veterans Administration, Wadsworth Hospital Center, Los Angeles, California 90073; * Departments of Medicine, Harbor General Hospital, Torrance, California 90509; and t UCLA School of Medicine, Los Angeles, California 90024 Communicated by William N. Valentine, June 1, 1978 ABSTRACr A quantitative technique for determining lipid tography-mass spectrometry. Mass spectrometry has been used A content of endotoxin added to serum by combined gas chro- successfully in the past to detect various biological compounds matography-mass spectrometry is described. This technique uses (26). This procedure is highly specific and very sensitive. detection of the -hydroxymyristic acid content of Salmonella The minnesota R595 lipopolysaccharide by selected ion monitoring method described in this communication quantitates nanogram at atomic mass unit of 315.4 The fatty acids produced on hy- quantities of lipid A and endotoxin in serum. drolysis of serum containing lipopolysaccharide were extracted and the methyl esters were made. Silica gel chromatography was MATERIALS AND METHODS used to separate methyl esters of hydroxy fatty acids from other Serum Samples. New Zealand white rabbits weighing ap- fatty acid methyl esters. Trimethylsilyl ether derivatives of the proximately 2 kg, and not fed overnight, were used. Blood was hydroxy fatty acid methyl ester fraction were quantitated by this technique. As little as 200 fmol of fi-hydroxymyristic acid obtained by heart puncture under sterile conditions.
    [Show full text]